News
Vitiligo is a skin condition caused by the loss of a pigment called melanin in certain areas, resulting in white or lighter patches that contrast with the person’s natural skin tone. While vitiligo is ...
2d
MedPage Today on MSNPhototherapy Promising as Add-On to Oral Ritlecitinib for VitiligoAdding narrowband ultraviolet B (UVB) phototherapy to oral treatment with ritlecitinib (Litfulo) enhanced repigmentation in ...
Vitiligo pada bayi bisa hilang seiring bertambahnya usia, namun Parents dapat melakukan beberapa perawatan berikut ini.
A study identifies three clinically distinct profiles of patients with vitiligo on the basis of emotional, psychological, and ...
Adolescence is a time when most people start thinking about how they appear to others. But Mini faced a different reality. At ...
The British Skin Foundation states that often no treatment may be required but that options can include: Sunscreens: Areas of vitiligo will burn easily in the sun. The use of a sunscreen with a ...
Incyte is preparing to take an oral JAK inhibitor into phase 3 trials for the skin depigmentation disease vitiligo, after reporting mid-stage data showing efficacy in patients with facial and full ...
Narrowband UVB (nbUVB) phototherapy may be underutilized in pediatric vitiligo, according to a study published online March ...
If approved, Opzelura would provide an alternative to steroid drugs currently used to treat vitiligo, a chronic autoimmune disease that causes depigmentation of skin and affects around 1.5 million ...
“As novel therapies for vitiligo emerge, it is important to ensure ... or consulting for various companies, including Apogee, Skin Analytics, Alys Pharmaceuticals, and Sanofi.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results